For patients already on CPAP who later started GLP-1 therapy, Resmed found two-year CPAP resupply rates were 5.1% higher and three-year resupply rates were 6.2% higher than among patients on CPAP alone, according to Nunez
Both GIPR-Ab/P1 and GIPR-Ab/P2 maintained robust GIPR antagonistic actions on both human and monkey-derived GIPRs, with IC50 values comparable to the original GIPR antibody, indicating that chemical conjugation did not diminish the GIPR antagonistic activity
HealthRX positions itself as the definitive solution for individuals who have been shut out of traditional insurance routes, providing immediate access to semaglutide and other GLP-1 treatments that are reshaping the weight management industry
What the data does not tell us Honesty matters more than hype
Positive reviews praise the Noom program for its effectiveness at reaching their weight loss goal, but critical reviews criticize the high price
What was once investigational is now reality